Central Nervous System Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Trigeminal Neuralgia (Tic Douloureux) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ges, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape.
Trigeminal neuralgia is a chronic pain condition that affects the trigeminal......" | 31-Mar-2022 | $2000 | |
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... (ADHD) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape.
Attention de......" | 31-Mar-2022 | $2000 | |
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape.
Spinal muscular atrophy (SMA) is a genetic disease that attacks ne......" | 31-Mar-2022 | $2000 | |
Cerebral Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... le Type and Key Players, 2022 Update, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape.
Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as movement, l......" | 31-Mar-2022 | $2000 | |
Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... d With Schizophrenia (CIAS) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline landsc......" | 31-Mar-2022 | $2000 | |
Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Key Players, 2022 Update, provides an overview of the Sedation (Central Nervous System) pipeline landscape.
Sedation is the depression of irritability or agitation. Symptoms include talk slowly and may slur their speech, unable to concen......" | 31-Mar-2022 | $2000 | |
Post-Operative Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... oA, Molecule Type and Key Players, 2022 Update, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.
Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of p......" | 31-Mar-2022 | $2500 | |
Alcohol Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Molecule Type and Key Players, 2022 Update, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape.
Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decre......" | 31-Mar-2022 | $2000 | |
Obsessive-Compulsive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Obsessive-Compulsive Disorder (Central Nervous System) pipeline landscape.
Obsessive-compulsive disorder (OCD) is characterized by unreasonab......" | 31-Mar-2022 | $2000 | |
Post-Traumatic Stress Disorder (PTSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... evelopment by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline landscape.
Post-traumatic stress disorder (PTSD) is a......" | 31-Mar-2022 | $2000 | |
|